Literature DB >> 27013137

Editorial Commentary: Understanding Marfan syndrome, or "how not to invent the light bulb".

Jeffrey A Jones1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27013137      PMCID： PMC4912448          DOI： 10.1016/j.tcm.2016.02.005

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN： 1050-1738            Impact factor:   6.677


× No keyword cloud information.
  35 in total

1.  Angiotensin II upregulates transforming growth factor-beta type I receptor on rat vascular smooth muscle cells.

Authors:  N Fukuda; W Y Hu; A Kubo; H Kishioka; C Satoh; M Soma; Y Izumi; K Kanmatsuse
Journal:  Am J Hypertens       Date:  2000-02       Impact factor: 2.689

2.  The αvβ1 integrin plays a critical in vivo role in tissue fibrosis.

Authors:  Nilgun I Reed; Hyunil Jo; Chun Chen; Kazuyuki Tsujino; Thomas D Arnold; William F DeGrado; Dean Sheppard
Journal:  Sci Transl Med       Date:  2015-05-20       Impact factor: 17.956

Review 3.  Recent progress in genetics of Marfan syndrome and Marfan-associated disorders.

Authors:  Takeshi Mizuguchi; Naomichi Matsumoto
Journal:  J Hum Genet       Date:  2006-10-24       Impact factor: 3.172

4.  Atenolol versus losartan in children and young adults with Marfan's syndrome.

Authors:  Ronald V Lacro; Harry C Dietz; Lynn A Sleeper; Anji T Yetman; Timothy J Bradley; Steven D Colan; Gail D Pearson; E Seda Selamet Tierney; Jami C Levine; Andrew M Atz; D Woodrow Benson; Alan C Braverman; Shan Chen; Julie De Backer; Bruce D Gelb; Paul D Grossfeld; Gloria L Klein; Wyman W Lai; Aimee Liou; Bart L Loeys; Larry W Markham; Aaron K Olson; Stephen M Paridon; Victoria L Pemberton; Mary Ella Pierpont; Reed E Pyeritz; Elizabeth Radojewski; Mary J Roman; Angela M Sharkey; Mario P Stylianou; Stephanie Burns Wechsler; Luciana T Young; Lynn Mahony
Journal:  N Engl J Med       Date:  2014-11-18       Impact factor: 91.245

5.  Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism.

Authors:  Juan Rodríguez-Vita; Elsa Sánchez-López; Vanesa Esteban; Mónica Rupérez; Jesús Egido; Marta Ruiz-Ortega
Journal:  Circulation       Date:  2005-05-09       Impact factor: 29.690

6.  MMP-2 regulates Erk1/2 phosphorylation and aortic dilatation in Marfan syndrome.

Authors:  Wanfen Xiong; Trevor Meisinger; Rebecca Knispel; Jennifer M Worth; B Timothy Baxter
Journal:  Circ Res       Date:  2012-05-01       Impact factor: 17.367

7.  Aneurysm syndromes caused by mutations in the TGF-beta receptor.

Authors:  Bart L Loeys; Ulrike Schwarze; Tammy Holm; Bert L Callewaert; George H Thomas; Hariyadarshi Pannu; Julie F De Backer; Gretchen L Oswald; Sofie Symoens; Sylvie Manouvrier; Amy E Roberts; Francesca Faravelli; M Alba Greco; Reed E Pyeritz; Dianna M Milewicz; Paul J Coucke; Duke E Cameron; Alan C Braverman; Peter H Byers; Anne M De Paepe; Harry C Dietz
Journal:  N Engl J Med       Date:  2006-08-24       Impact factor: 91.245

8.  Beneficial Outcome of Losartan Therapy Depends on Type of FBN1 Mutation in Marfan Syndrome.

Authors:  Romy Franken; Alexander W den Hartog; Teodora Radonic; Dimitra Micha; Alessandra Maugeri; Fleur S van Dijk; Hanne E Meijers-Heijboer; Janneke Timmermans; Arthur J Scholte; Maarten P van den Berg; Maarten Groenink; Barbara J M Mulder; Aeilko H Zwinderman; Vivian de Waard; Gerard Pals
Journal:  Circ Cardiovasc Genet       Date:  2015-01-22

9.  Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.

Authors:  Benjamin S Brooke; Jennifer P Habashi; Daniel P Judge; Nishant Patel; Bart Loeys; Harry C Dietz
Journal:  N Engl J Med       Date:  2008-06-26       Impact factor: 91.245

Review 10.  Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders.

Authors:  H C Dietz; R E Pyeritz
Journal:  Hum Mol Genet       Date:  1995       Impact factor: 6.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.